San Francisco, CA, United States of America

Daniel John Cloutier

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Achaogen, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel John Cloutier. Retrieved from https://idiyas.com/inventor/daniel-john-cloutier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel John Cloutier

Introduction

Daniel John Cloutier is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections. His innovative approach has led to the development of a unique patent that addresses critical medical needs.

Latest Patents

Daniel John Cloutier holds a patent for "Combination products for the treatment of bacterial infections and methods of producing or dosing of same." This patent outlines methods for treating bacterial infections by administering ceftibuten or its pharmaceutically acceptable salts, along with clavulanic acid or its salts. The patent also includes pharmaceutical compositions, articles of manufacture, and kits that utilize these compounds for effective treatment.

Career Highlights

Cloutier is associated with Achaogen, Inc., a company focused on developing innovative antibiotics. His work at Achaogen has been pivotal in advancing treatments for serious bacterial infections, showcasing his commitment to improving healthcare outcomes.

Collaborations

Throughout his career, Cloutier has collaborated with notable colleagues, including Ryan Cirz and Kevin Michael Krause. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Daniel John Cloutier's contributions to the field of pharmaceuticals through his innovative patent and work at Achaogen, Inc. highlight his dedication to addressing critical health challenges. His efforts continue to pave the way for advancements in the treatment of bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…